Jacobs Levy Equity Management
DMTX

Jacobs Levy Equity Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

Jacobs Levy Equity Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-61,207
Closed -$266K – 1095
2016
Q4 		$266K Buy
61,207
+30,707
+101% +$163K 0.01% 790
2016
Q3 		$244K Buy
30,500
+1,200
+4% +$8.68K ﹤0.01% 855
2016
Q2 		$176K Buy
+29,300
New +$223K ﹤0.01% 1031

Other funds holding DMTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Jacobs Levy Equity Management's DMTX Position: Q1 2017 in Review

Jacobs Levy Equity Management sold out of Dimension Therapeutics, Inc (DMTX) in Q1 2017, closing a stake of 61,207 shares — an estimated $266K sold.

Jacobs Levy Equity Management first reported a position in DMTX in Q2 2016 and held it in 3 quarters. The position peaked at $266K in Q4 2016. 47 funds tracked by Wall St. Rank hold DMTX as of Q1 2017.

  • Jacobs Levy Equity Management reported no remaining Dimension Therapeutics, Inc position as of Q1 2017 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 61,207 Dimension Therapeutics, Inc shares in Q1 2017, an estimated $266K.
  • Jacobs Levy Equity Management first reported a position in Dimension Therapeutics, Inc in Q2 2016 and held it in 3 quarters.
  • Jacobs Levy Equity Management's Dimension Therapeutics, Inc position peaked at $266K in Q4 2016.
  • 47 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q1 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2017, filed 15 May 2017.